News and Analysis
Innovation, Technology, and IP News
Featured Project Development: State of the Art Novel InFlow Tech: ·1-Gearturbine Reaction Turbine Rotary Turbo, ·2-Imploturbocompressor Impulse Turbine 1 ... Read More »
Featured Project Development - State of the Art Novel InFlow Technology:
·1-Gearturbine, Rotary-Turbo, ·2-Imploturbocompressor, One Compression ... Read More »
Comments
Novartis AG: Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in... Read More »
Automobiles, smartphones, laptops, medical devices, among other end products, contain scores of individual components supplied by vendors. For end products sold... Read More »
In January, the USPTO announced it would seek comments on the new Guidance it had published on patent subject matter eligibility. We have previously discussed this... Read More »
Review it please. This can be a good article to read and if found possible try to share with your friends if you find useful for them
Tesla Inc reported a net profit, positive cash flow and wider-than-expected margins for the latest quarter on Wednesday, delivering on Chief Executive Elon Musk's... Read More »
If you look through the U.S. Patent Office’s online database, you’ll find some head-scratching proposals for inventions: for a plan to stack airplane... Read More »
For "X" drug, I prepared solvate "Xz." Using "Xz" I prepared Granules Dosage Form. Over the period of stability I found that solvate... Read More »
Total Approved NMEs: 46
Small Molecules: 34 (74 %)
Biologics: 12 (26 %)
This is second best production rate of approvals since 1996 when 53 NME's... Read More »
Patent Application is related to accurate capability for determining whether a Luciferian may be rehabilitated.
As per Patent Specification (Paragraph: 0006)... Read More »
Comments
Sanofi's Admelog (Short Acting Insulin) approved as a "follow-on product" on December 11, 2017 by US FDA's 505(b)(2) pathway.
... Read More »
The new standard, ITU Y.2241, details a web service framework to support ‘ubiquitous self-directed learning’ in future networks. It supports adaptive... Read More »
Comments
Written by Scott Siera, Ph.D. and Eric Furman, Ph.D.
Seven years after Mylotarg® (gemtuzumab ozogamicin) was voluntarily withdrawn from the market, the U.S... Read More »
Written by Damien Howard and Ronald J. Schoenbaum
The Federal Circuit recently decided a patent subject-matter eligibility case relating to computer memory in... Read More »
If you live or work in the part of the country between Atlanta and Charlotte, I have some information that might be of interest to you. Clemson University... Read More »